x 

0 Activities
0 Activities
    • No Saved Activities

Slides

  2. Home
  3. Education
  4. Content Type
  5. Slides
  6. Specialty Area
Page 5 of 21
Results 121 - 150 of 619
lyso
Emerging Biomarker Strategies for Lysosomal Storage Diseases
9262 ntm gr enduring
NTM-LD: Improving Diagnosis, Individualized Treatment, and Adherence
animation-263x149
Encouraging Shared Decision-Making with MS Patients
9252 schiz
Cognitive Impairment Associated With Schizophrenia
9194 chILD module
Childhood ILD: Increasing Awareness, Diagnosis, & Patient Management
9235-0005_thumb
Recent Developments in Immune Therapies for Multiple Sclerosis
9444 fabry
A Focus on Fabry Disease: An EXPLORE™ eLearning Module
9256-0001-Thumb
Spring Neuromuscular Conference Updates
9263 NCFBE
The Burden of Bronchiectasis: A Focus on NCFBE Pathophysiology
9235-mod4-263x149
The Connection Between Viruses and Other Factors Contributing to the Development of MS
9193-case3
SSc-ILD With Rapid Progression
9193-case2
Delayed Diagnosis of SSc-ILD with PPF
9235-panel1
Advances in the Understanding of MS Immunology, Therapies, & Biomarkers
9235-panel2
Individualized Care Plans and Emerging Tools for Patient Monitoring
9235-berger-mod
The Role of B Cells in Progressive MS and the Long-term Effects of B Cell Depletion
9199-hepatic2
Treating HCC Cases with Locoregional and Systemic Therapies
9199-hepatic1
Evolving Systemic Treatments for Hepatocellular Carcinoma: Multidisciplinary Strategies
9185-combined
Biomarker-Driven Treatment of Metastatic Colorectal Cancer
9193-case1
Identifying the Signs and Symptoms of PPF
9191-icos
Treating & Assessing Treatment Response: AL Amyloidosis
Option05
The Advancing Treatment Landscape in Amyloidosis: Are You Ready?
9232-module1
Identify the Etiology of Aplastic Anemia in Patients
9232-module2
Recognizing Risk and Benefits of Management Options for Aplastic Anemia
9232-module3
Considerations for Special Populations With Aplastic Anemia
9198-start
Stroke Prevention Through Afib Recognition & Treatment
9234 kca
Immune Checkpoint Inhibitors and RCC: Where Are We Now?
9171-ash-explore
Gene Therapy for Hemophilia: An EXPLORE Learning Experience
9197-hcc1
Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT
01.DMD-VirtueMart5
DMD Micro-Learning Library
cttp_thumb_264x150
cTTP: Protecting Patients, Today and Tomorrow
Page 5 of 21

Search